Target-achieved propofol concentration during on-pump cardiac surgery: A pilot dose-finding study

Canadian Journal of Anesthesia

Volumn 56, Issue 9, 2009, Pages 658-666

  Raedschelders, Koen ^a   Hui, Yu ^a   Laferlita, Bradley ^a   Luo, Tao ^a   Zhang, Hong ^a   Chen, David D Y ^a   Ansley, David M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; GLYCERYL TRINITRATE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PROPOFOL;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; FEMALE; HEART INDEX; HEART PROTECTION; HEART VENTRICLE WORK; HEMODYNAMICS; HUMAN; INFUSION PUMP; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SYSTEMIC VASCULAR RESISTANCE;

AGED; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; CARDIAC OUTPUT; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROPOFOL; REPERFUSION INJURY; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 69249230733     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-009-9145-3     Document Type: Article

References (45)

1. HM Piper K Meuter C Schafer 2003 Cellular mechanisms of ischemia-reperfusion injury Ann Thorac Surg 75 S644 S648
2. SG De Hert S Cromheecke PW ten Broecke, et al. 2003 Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients Anesthesiology 99 314 323
3. JA Symons PS Myles 2006 Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis Br J Anaesth 97 127 136
4. CH Yu WS Beattie 2006 The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis Can J Anesth 53 906 918
5. L Tritapepe G Landoni F Guarracino, et al. 2007 Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass Eur J Anaesthesiol 24 323 331
6. V Piriou J Mantz G Goldfarb, et al. 2007 Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial Br J Anaesth 99 624 631
7. X Wang O Jarvinen P Kuukasjarvi, et al. 2004 Isoflurane produces only minor preconditioning in coronary artery bypass grafting Scand Cardiovasc J 38 287 292 (Pubitemid 39462159)
8. K Tanaka F Kehl W Gu, et al. 2002 Isoflurane-induced preconditioning is attenuated by diabetes Am J Physiol Heart Circ Physiol 282 H2018 H2023
9. ML Riess DF Stowe DC Warltier 2004 Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol 286 H1603 H1607
10. LG Kevin P Katz AK Camara E Novalija ML Riess DF Stowe 2003 Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts Anesthesiology 99 385 391 (Pubitemid 36909564)
11. GJ Gross JA Auchampach 2007 Reperfusion injury: does it exist? J Mol Cell Cardiol 42 12 18
12. DM Ansley J Lee DV Godin ME Garnett AK Qayumi 1998 Propofol enhances red cell antioxidant capacity in swine and humans Can J Anaesth 45 233 239
13. HS Kim WC Chang KC Hwang IG Choi WK Park 2008 Effect of propofol on calcium homeostasis in hypoxia-reoxygenated neonatal rat cardiomyocytes Eur J Pharmacol 594 139 145
14. B Wang T Luo D Chen DM Ansley 2007 Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells Anesth Analg 105 1027 1033
15. F Sztark F Ichas R Ouhabi P Dabadie JP Mazat 1995 Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential FEBS Lett 368 101 104
16. SA Javadov KH Lim PM Kerr MS Suleiman GD Angelini AP Halestrap 2000 Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition Cardiovasc Res 45 360 369
17. SG De Hert PW ten Broecke E Mertens, et al. 2002 Sevoflurane but not propofol preserves myocardial function in coronary surgery patients Anesthesiology 97 42 49
18. Y Karashima M Oike S Takahashi Y Ito 2002 Propofol prevents endothelial dysfunction induced by glucose overload Br J Pharmacol 137 683 691
19. SH Ko CW Yu SK Lee, et al. 1997 Propofol attenuates ischemia-reperfusion injury in the isolated rat heart Anesth Analg 85 719 724
20. Z Xia DV Godin DM Ansley 2004 Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity Can J Physiol Pharmacol 82 919 926
21. Z Xia DV Godin TK Chang DM Ansley 2003 Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation Can J Physiol Pharmacol 81 14 21
22. N Kokita A Hara Y Abiko J Arakawa H Hashizume A Namiki 1998 Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts Anesth Analg 86 252 258
23. S Mathur P Farhangkhgoee M Karmazyn 1999 Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) Anesthesiology 91 1349 1360
24. KH Lim AP Halestrap GD Angelini MS Suleiman 2005 Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass Exp Biol Med (Maywood) 230 413 420
25. N Kamada N Kanaya N Hirata S Kimura A Namiki 2008 Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3beta Can J Anesth 55 595 605
26. K Yoshitani M Kawaguchi M Takahashi K Kitaguchi H Furuya 2003 Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass Br J Anaesth 90 122 126
27. H Hiraoka K Yamamoto N Okano T Morita F Goto R Horiuchi 2004 Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding Clin Pharmacol Ther 75 324 330
28. DA Rosen KR Rosen 1997 Elimination of drugs and toxins during cardiopulmonary bypass J Cardiothorac Vasc Anesth 11 337 340
29. DM Ansley J Sun WA Visser, et al. 1999 High dose propofol enhances red cell antioxidant capacity during CPB in humans Can J Anesth 46 641 648
30. Z Xia Z Huang DM Ansley 2006 Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane Anesth Analg 103 527 532
31. DM Ansley K Raedschelders DD Chen PT Choi 2009 Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery Contemp Clin Trials 30 380 385
32. Y Hui K Raedschelders H Zhang DM Ansley DD Chen 2009 Quantitative analysis of propofol in whole blood using capillary electrophoresis J Chromatogr B Analyt Technol Biomed Life Sci 877 703 709
33. E Gepts F Camu ID Cockshott EJ Douglas 1987 Disposition of propofol administered as constant rate intravenous infusions in humans Anesth Analg 66 1256 1263
34. PJ Dawson AR Bjorksten DW Blake JC Goldblatt 1997 The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam J Cardiothorac Vasc Anesth 11 556 561
35. E Hammaren A Yli-Hankala PH Rosenberg M Hynynen 1996 Cardiopulmonary bypass-induced changes in plasma concentrations of propofol and in auditory evoked potentials Br J Anaesth 77 360 364
36. E Takizawa H Hiraoka D Takizawa F Goto 2006 Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass Br J Anaesth 96 179 185
37. NJ Massey KM Sherry S Oldroyd JE Peacock 1990 Pharmacokinetics of an infusion of propofol during cardiac surgery Br J Anaesth 65 475 479
38. H Shao J Li Y Zhou, et al. 2008 Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin Br J Pharmacol 153 1641 1649
39. J Schuttler H Ihmsen 2000 Population pharmacokinetics of propofol: a multicenter study Anesthesiology 92 727 738
40. HB Su TY Chen CF Cheng YJ Yang JD Huang CC Tseng 2003 The hypotensive effects of propofol at different sampling sites in cardiopulmonary bypass model Acta Anaesthesiol Sin 41 125 130
41. M Grossherr A Hengstenberg T Meier L Dibbelt K Gerlach H Gehring 2006 Discontinuous monitoring of propofol concentrations in expired alveolar gas and in arterial and venous plasma during artificial ventilation Anesthesiology 104 786 790
42. JF Coetzee JB Glen CA Wium L Boshoff 1995 Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets Anesthesiology 82 1328 1345
43. H Hiraoka K Yamamoto S Miyoshi, et al. 2005 Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain Br J Clin Pharmacol 60 176 182
44. E Major C Aun PM Yate, et al. 1983 Influence of sample site on blood concentrations of ICI 35868 Br J Anaesth 55 371 375
45. DG Levitt TW Schnider 2005 Human physiologically based pharmacokinetic model for propofol BMC Anesthesiol 5 4